Author:
Ramírez Jacqueline,Wu Kehua,Janisch Linda,Karrison Theodore,House Larry K.,Innocenti Federico,Cohen Ezra E. W.,Ratain Mark J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference14 articles.
1. Gupta E, Lestingi TM, Mick R, Ramirez J, Vokes EE, Ratain MJ (1994) Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. Cancer Res 54:3723–3725
2. Govindarajan R (2000) Irinotecan and thalidomide in metastatic colorectal cancer. Oncology (Williston Park) 14:29–32
3. Govindarajan R, Heaton KM, Broadwater R, Zeitlin A, Lang NP, Hauer-Jensen M (2000) Effect of thalidomide on gastrointestinal toxic effects of irinotecan. Lancet 356:566–567
4. Govindarajan R (2002) Irinotecan/thalidomide in metastatic colorectal cancer. Oncology (Williston Park) 16:23–26
5. Miller AA, Case D, Atkins JN, Giguere JK, Bearden JD (2006) Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer. J Thorac Oncol 1:832–836
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献